| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $396K | +105.2% | -81.8% |
| R&D Expense | $32.5M | +23.8% | +27.2% |
| SG&A Expense | $8.2M | -7.6% | +25.5% |
| Operating Income | -$40.3M | -15.3% | -34.7% |
| Net Income | -$36.8M | -16.2% | -46.0% |
| EPS (Basic) | -$0.97 | -10.2% | -31.1% |
| EPS (Diluted) | -$0.97 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $56.0M | +322.9% | +66.3% |
| Short-term Investments | $346.6M | +42.0% | +40.1% |
| Accounts Receivable | $5.0M | — | +259.7% |
| Current Assets | $413.8M | +57.0% | +43.9% |
| Total Assets | $577.4M | +77.1% | +63.0% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$82.1M | — | — |
| Capital Expenditures | $75K | — | — |
| Investing Cash Flow | -$160.0M | — | — |
| Financing Cash Flow | $275.2M | — | — |
| Free Cash Flow | -$82.2M | — | — |
| -10.2% |
| -31.1% |
| $23.9M |
| +18.7% |
| +51.8% |
| Total Liabilities | $31.0M | +34.8% | +89.5% |
| Stockholders' Equity | $546.5M | +80.3% | +61.7% |